BioRegenx (BioRegenx) Interest Expense : $-0.08 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is BioRegenx Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. BioRegenx's interest expense for the three months ended in Mar. 2024 was $ -0.07 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. BioRegenx's Operating Income for the three months ended in Mar. 2024 was $ -0.64 Mil. BioRegenx's Interest Expense for the three months ended in Mar. 2024 was $ -0.07 Mil. BioRegenx did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioRegenx Interest Expense Historical Data

The historical data trend for BioRegenx's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Interest Expense Chart

BioRegenx Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.01

BioRegenx Quarterly Data
	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.05	-	-	-	-0.07

BioRegenx Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.08 Mil.

BioRegenx (OTCPK:BRGX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioRegenx's Interest Expense for the three months ended in Mar. 2024 was $-0.07 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-0.64 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.15 Mil.

BioRegenx's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

BioRegenx did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

BioRegenx (BioRegenx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

5051 Peachtree Corners Circle, No. 200, Peachtree Corners, GA, USA, 30092

Website

https://www.findit.com

Findit Inc owns Findit.com and the Findit App. Findit.com and the Findit App operate as a Social Media Content Management Platform, that includes its own search engine. Members can utilize Findit search to submit URLs they want Findit to index in Findit search results. Nonmembers can come to Findit and enter search queries, Findit returns matching search results from content posted in Findit along with outside web pages that have been submitted.